A comprehensive approach to treating chronic recurrent uncomplicated cystitis during pregnancy

Tyutyunnik V.L., Mikhailova O.I., Kan N.E., Mirzabekova D.D.

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia
Objective: To evaluate the efficiency of combination therapy for chronic recurrent uncomplicated cystitis during pregnancy.
Materials and methods: The investigation enrolled 50 pregnant women with chronic recurrent uncomplicated cystitis in the second or third trimester. There were two equal formed groups: 1) a study group that included 25 women who received combination treatment with an antibiotic and an immunomodulatory agent; 2) a comparison group that consisted of 25 women who took an antibiotic only. The efficiency of different treatment regimens for chronic recurrent uncomplicated cystitis was evaluated, by analyzing laboratory data, assessing the Acute Cystitis Symptom Score (ACSS) questionnaire, determining the immune status, and analyzing the characteristics of the course of labor and perinatal outcomes.
Results: Therapy with an antibiotic in combination with the immunomodulatory agent Superlymph showed the greatest efficiency in treating chronic recurrent uncomplicated cystitis. In the study group, leukocytosis during a urinalysis and the growth of pathogens during microscopic examination were most significantly decreased; positive changes in the indicators of innate immunity were more pronounced; the period between exacerbations of cystitis was much longer and the duration of relapses was shorter; and the quality of life became substantially better, as shown by the ACSS questionnaire. In addition, this patient cohort was recorded to have the most favorable obstetric and perinatal outcomes.
Conclusion: The immunomodulatory agent Superlymph in combination with an antibiotic can be recommended for use in the therapy of chronic recurrent uncomplicated cystitis in the second or third trimester of pregnancy, which significantly increases the efficiency of the performed treatment.

Keywords

cystitis
pregnancy
fosfomycin
immunomodulatory therapy
Superlymph

References

  1. Министерство здравоохранения Российской Федерации. Цистит у женщин. Клинические рекомендации (протокол лечения). М.; 2021. 59 с. [Ministry of Health of the Russian Federation. Cystitis in women. Clinical guidelines (treatment protocol). Moscow; 2021. 59 p. (in Russian)].
  2. Аляев Ю.Г., Глыбочко П.В., Пушкарь Д.Ю., ред. Урология. Российские клинические рекомендации. M.: ГЭОТАР-Медиа; 2016. 496 с. [Alyaev Yu.G., Glybochko P.V., Pushkar D.Yu., ed. Urology. Russian clinical guidelines. Moscow: GEOTAR-Media; 2016. 496 p. (in Russian)].
  3. Министерство здравоохранения Российской Федерации. Инфекция мочевых путей при беременности. Клинические рекомендации. М.; 2021. 47с. [Ministry of Health of the Russian Federation. Urinary tract infection during pregnancy. Clinical guidelines. Moscow; 2021. 47 p. (in Russian)].
  4. Kolman K.B. Cystitis and pyelonephritis: diagnosis, treatment, and prevention. Prim. Care. 2019; 46(2): 191-202. https://dx.doi.org/ 10.1016/j.pop.2019.01.001.
  5. Ny S., Edquist P., Dumpis U., Gröndahl-Yli-Hannuksela K., Hermes J., Kling A.M. et al.; NoDARS UTIStudy Group. Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia. J. Glob. Antimicrob. Resist. 2019; 17: 25-34. https://dx.doi.org/10.1016/j.jgar.2018.11.004.
  6. Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015; 13(5): 269-84. https://dx.doi.org/10.1038/nrmicro3432.
  7. Shang Y.J., Wang Q.Q., Zhang J.R., Xu Y.L., Zhang W.W., Chen Y. et al. Systematic review and meta-analysis of flow cytometry in urinary tract infection screening. Clin. Chim. Acta. 2013; 424: 90-5. https://dx.doi.org/10.1016/j.cca.2013.05.014.
  8. Apodaca G. The uroepithelium: not just a passive barrier. Traffic. 2004; 5(3): 117-28. https://dx.doi.org/10.1046/j.1600-0854.2003.00156.x.
  9. Glaser A.P., Schaeffer A.J. Urinary tract infection and bacteriuria in pregnancy. Urol. Clin. North Am. 2015; 42(4): 547-60. https://dx.doi.org/10.1016/j.ucl.2015.05.004.
  10. Pietrucha-Dilanchian P., Hooton T.M. Diagnosis, Treatment, and Prevention of Urinary Tract Infection. Microbiol Spectr. 2016; 4(6). https://dx.doi.org/10.1128/microbiolspec.UTI-0021-2015.
  11. Henderson J.T., Webber E.M., Bean S.I. Screening for asymptomatic bacteriuria in adults: An updated systematic review for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); Sep. 2019. Report No.: 19-05252-EF-1.
  12. Schneeberger C., Geerlings S.E., Middleton P., Crowther C.A. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst. Rev. 2015; 2015(7): CD009279. https://dx.doi.org/10.1002/14651858.CD009279.pub3.
  13. Kazemier B.M., Koningstein F.N., Schneeberger C., Ott A., Bossuyt P.M., de Miranda E. et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomized controlled trial. Lancet Infect. Dis. 2015; 15(11): 1324-33. https://dx.doi.org/10.1016/S1473-3099(15)00070-5.
  14. Smaill F.M., Vazquez J.C. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst. Rev. 2019; 2019(11): CD000490. https://dx.doi.org/10.1002/14651858.CD000490.
  15. Ghouri F., Hollywood A., Ryan K. A systematic review of non-antibiotic measures for the prevention of urinary tract infections in pregnancy. BMC Pregnancy Childbirth. 2018; 18(1): 99. https://dx.doi.org/10.1186/s12884-018-1732-2.
  16. Choe H.S., Lee S.J., Yang S.S., Hamasuna R., Yamamoto S., Cho Y.H., Matsumoto T.; Committee for Development of the UAA-AAUS Guidelines for UTI and STI. Summary of the UAA-AAUS guidelines for urinary tract infections. Int. J. Urol. 2018; 25(3): 175-85. https://dx.doi.org/10.1111/iju.13493.
  17. Балушкина А.А., Кан Н.Н., Тютюнник В.Л. Современный взгляд на терапию инфекций мочевыводящих путей у беременных. РМЖ. Медицинское обозрение. 2018; 2[8(1)]: 37-40. [Balushkina A.A., Kan N.E., Tyutyunnik V.L. A modern view on the treatment of urinary tract infections in pregnant women. Russian Medical Journal. Medical review. 2018; 8(1): 37-40. (in Russian)].
  18. Gonzalez E.J., Arms L., Vizzard M.A. The role(s) of cytokines/chemokines in urinary bladder inflammation and dysfunction. Biomed. Res. Int. 2014; 2014: 120525. https://dx.doi.org/10.1155/2014/120525.
  19. Аполихина И.А., Саидова А.С., Тетерина Т.А. Эффективность применения локальной цитокинотерапии в комплексном лечении пациенток с хроническим циститом. Акушерство и гинекология. 2019; 12: 167-72. [Apolikhina I.A., Saidova A.S., Teterina T.A. Efficiency of local cytokine therapy used in the combination treatment of female patients with chronic cystitis. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2019; 12:167-72. (in Russian)]. https://dx.doi.org/10.18565/aig.2019.12.167-172.
  20. Kalinderi K., Delkos D., Kalinderis M., Athanasiadis A., Kalogiannidis I. Urinary tract infection during pregnancy: current concepts on a common multifaceted problem. J. Obstet. Gynaecol. 2018; 38(4): 448-53.https://dx.doi.org/10.1080/01443615.2017.1370579.
  21. Боровкова Е.И., Залесская С.А., Степанянц И.В. Сравнительная эффективность влагалищного и ректального применения цитокинотерапии у беременных с дисплазией шейки матки. Русский медицинский журнал. Мать и дитя. 2019; 2(3): 173-6. [Borovkova E.I., Zalesskaya S.A., Stepanyants I.V. Comparative efficacy of vaginal and rectal cytokine therapy in pregnant women with cervical dysplasia. Russian medical journal. Mother and child. 2019; 2(3): 173-6. (in Russian)]. https://dx.doi.org/10.32364/2618-8430-2019-2-3-173-176.

Received 19.07.2022

Accepted 26.07.2022

About the Authors

Victor L. Tyutyunnik, Professor, MD, PhD, Leading Researcher of Research and Development Service, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology Ministry of Health of Russia, +7(903)969-50-41, tioutiounnik@mail.ru, Researcher ID: B-2364-2015, SPIN-код: 1963-1359,
Authors ID: 213217, Scopus Author ID: 56190621500, https://orcid.org/0000-0002-5830-5099, 117997, Russia, Moscow, Ac. Oparina str., 4.
Olga I. Mikhailova, PhD, Researcher, 2 Maternity Department, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, +7(926)564-68-13, omikhaylova@gmail.com, https://orcid.org/0000-0001-7569-8704, 117997, Russia, Moscow, Ac. Oparina str., 4.
Natalia E. Kan, Professor, MD, PhD, Deputy Director of Science, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology Ministry of Health of Russia, +7(926)220-86-55, kan-med@mail.ru, Researcher ID: B-2370-2015, SPIN-код: 5378-8437, Authors ID: 624900, Scopus Author ID: 57008835600, https://orcid.org/0000-0001-5087-5946, 117997, Russia, Moscow, Ac. Oparina str., 4.
Dzhamilia D. Mirzabekova, graduate student, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology Ministry of Health of Russia, +7(906)110-51-13, +7(920)984-94-07, Jamilya1705@yandex.ru, https://orcid.org/0000-0002-2391-3334, 117997, Russia, Moscow, Ac. Oparina str., 4.

Authors' contributions: Tyutyunnik V.L., Mikhailova O.I., Kan N.E., Mirzabekova D.D. – developing the design of the investigation, obtaining the data to be analyzed, review of publications on the topic of the article, statistical analysis of the findings, writing the text of the manuscript.
Conflicts of interest: The authors declare that there are no possible conflicts of interest.
Funding: The investigation has not been sponsored.
Ethical Approval: The investigation has been approved by the Ethics Committee of the V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia.
Patient Consent for Publication: All patients provided informed consent for the publication of their data.
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Tyutyunnik V.L., Mikhailova O.I., Kan N.E., Mirzabekova D.D.
A comprehensive approach to treating chronic recurrent uncomplicated cystitis during pregnancy.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2022; 8: 124-130 (in Russian)
https://dx.doi.org/10.18565/aig.2022.8.124-130

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.